First there were call centers and now, Biotechnology is now planning to rule over the ever-expanding Indian outsourcing industry.

As time passes by, it would seem that the tasks outsourced to India are becoming more and more sophisticated. Nowadays, outsourcing in India goes far more than IT outsourcing because there is now legal outsourcing, R&D, journalism outsourcing, and any other kind of outsourcing that you could think of.

Despite the expanding outsourcing industry, there are still challenges and obstacles that they have to go through particularly in Biotechnology outsourcing. One of the main challenges in this area is seed capital. Seed capital is needed in order to ensure that this outsourcing industry would grow and would really be a worthy investment.

Here is also an interesting quote from global consulting firm, Ernst and Young:

India's generics firms are positioning themselves to play a big role in the evolving biogenerics markets... It is also well poised to become a hub for processing and managing clinical data. Further, stem cell research will also help us create a niche.